Imperial College London

DrTarynYoungstein

Faculty of MedicineNational Heart & Lung Institute

Honorary Clinical Senior Lecturer
 
 
 
//

Contact

 

t.youngstein

 
 
//

Location

 

ICTEM buildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@inproceedings{Charania:2021:10.1182/blood-2021-148480,
author = {Charania, AS and Vergis, N and Phillips, R and Cornelius, V and Katsarou, A and Youngstein, T and Cook, L and Willicombe, M and Pilay, C and Shturova, T and Almonte, M and Charania, A and Turner, R and Kon, OM and Cooke, G and Thursz, M and Cherlin, S and Wason, J and Milojkovic, D and Innes, AJ and Cooper, N},
doi = {10.1182/blood-2021-148480},
pages = {4200--4200},
publisher = {American Society of Hematology},
title = {Multi-Arm Trial of Inflammatory Signal Inhibitors (MATIS) for hospitalised patients with mild or moderate Covid-19 pneumonia: a structured summary of a study protocol for a randomised controlled trial},
url = {http://dx.doi.org/10.1182/blood-2021-148480},
year = {2021}
}

RIS format (EndNote, RefMan)

TY  - CPAPER
AU - Charania,AS
AU - Vergis,N
AU - Phillips,R
AU - Cornelius,V
AU - Katsarou,A
AU - Youngstein,T
AU - Cook,L
AU - Willicombe,M
AU - Pilay,C
AU - Shturova,T
AU - Almonte,M
AU - Charania,A
AU - Turner,R
AU - Kon,OM
AU - Cooke,G
AU - Thursz,M
AU - Cherlin,S
AU - Wason,J
AU - Milojkovic,D
AU - Innes,AJ
AU - Cooper,N
DO - 10.1182/blood-2021-148480
EP - 4200
PB - American Society of Hematology
PY - 2021///
SN - 0006-4971
SP - 4200
TI - Multi-Arm Trial of Inflammatory Signal Inhibitors (MATIS) for hospitalised patients with mild or moderate Covid-19 pneumonia: a structured summary of a study protocol for a randomised controlled trial
UR - http://dx.doi.org/10.1182/blood-2021-148480
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000835740100201&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
UR - https://ashpublications.org/blood/article/138/Supplement%201/4200/481499/Multi-Arm-Trial-of-Inflammatory-Signal-Inhibitors
UR - http://hdl.handle.net/10044/1/104886
ER -